New Lows: LipoScience Inc (NASDAQ:LPDX), Exelixis (NASDAQ:EXEL), Charles & Colvard (NASDAQ:CTHR), KiOR Inc (NASDAQ:KIOR)

533

LipoScience, Inc. (NASDAQ:LPDX)’s shares dropped 19.63% to $3.03. The company on Mar. 28 announced the termination of its relationship with Health Diagnostics Laboratory, Inc. (“HDL Inc.”), one of its laboratory customers. On March 17, 2014, HDL Inc. began offering its own non-FDA cleared test for the measurement of low density lipoprotein particles (“LDL-P”). On last trading day LipoScience Inc (NASDAQ:LPDX) ended up -19.63% higher to close at $3.03 while trading in the range of $2.97 – $3.63. Its return on assets (ROA) is -14.40% while return on investment (ROI) is -10.10%. LipoScience Inc (NASDAQ:LPDX) monthly performance is -27.86%.

Exelixis, Inc. (NASDAQ:EXEL)’s shares dropped 6.74% to $3.60. The company on Mar. 25 announced that the Independent Data Monitoring Committee (IDMC) notified the company today that a planned interim analysis of the COMET-1 phase 3 pivotal trial has been completed, and that the IDMC recommended the trial proceed to its final analysis. Exelixis, Inc. (NASDAQ:EXEL) in last trading activity ended up at $3.38 with day range of $3.37 – $3.91. Company weekly performance is -46.26% while its quarterly performance stands at -43.85%. Exelixis, Inc. (NASDAQ:EXEL) is -59.81% away from its 52 week high.

Charles & Colvard, Ltd. (NASDAQ:CTHR) the sole source of created moissanite and Forever Brilliant®, The World’s Most Brilliant Gem®, reports sales for the three and 12 months ended December 31, 2013 increased 6% and 27%, respectively, over the prior-year periods. Charles & Colvard, Ltd. (NASDAQ:CTHR) belongs to Services sector with market capitalization of 58.94 M and has 2.90% insider ownership. In last trading activity company’s stock closed at $2.93 while opening price was $3.20.

Fred Cannon, the President and Chief Executive Officer of KiOR, Inc (NASDAQ:KIOR) notified the Company of his resignation as President, effective immediately. Mr. Cannon will continue to serve as the Company’s Chief Executive Officer and principal executive officer. On Friday shares of KiOR Inc (NASDAQ:KIOR) opened at $0.39 and closed at $0.410. This year Company’s Earnings per Share (EPS) growth is -253.30% and next year’s estimated EPS growth is -3.60%. Analysts mean target price for KiOR Inc (NASDAQ:KIOR) is $2.31.

Get Free Updates and Stock Alerts!



*We only send one email per week
Share.

Get Winning Stock Alerts!

Our track record speaks for itself! Our last 7 alerts have delivered combined gains in excess of 300% and there are no signs of slowing down. Join UltimateStockAlerts.com now before you miss out on our next big runner!

We will never sell or share your information.